相关实验视频

Updated: Jul 17, 2025

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

通过利用microRNAs进行细胞治疗

Marko Hasiuk¹, Marianne Dölz¹, Romina Marone¹

¹Department of Biomedicine, Basel University Hospital and University of Basel, Hebelstrasse 20, CH-4031 Basel, Switzerland; Transplantation Immunology & Nephrology, Basel University Hospital, Petersgraben 4, CH-4031 Basel, Switzerland.

Immunology letters

|September 3, 2023

概括

工程细胞疗法可以使用microRNAs (miRNAs) 增强,这是基因调节的关键层. 这种方法为开发更复杂,更有效的基于细胞的治疗提供了一个有希望的途径.

科学领域:

生物技术是生物技术.
分子生物学分子生物学
免疫治疗是一种免疫疗法.

背景情况:

自20世纪初以来,细胞疗法已经显著发展,从简单的输血到复杂的仿真抗原受体 (CAR) T细胞.
现代细胞工程利用细胞生物学和分子遗传学的进步来创造可编程的治疗细胞.
虽然蛋白质工程主导着细胞治疗的发展,但非编码RNA,特别是微RNA (miRNA),在转录后基因调节中起着至关重要的作用.

研究的目的:

突出将microRNAs (miRNAs) 纳入工程细胞疗法的潜力.
展示如何利用miRNA来增强治疗细胞的功能和精度.
强调在细胞工程中探索基于非编码RNA的策略的重要性.

主要方法:

审查有关微RNA功能和细胞工程技术的现有文献.
确定miRNAs已成功集成到基于细胞的工程治疗策略中的例子.
分析miRNA结合对细胞行为和治疗结果的影响.

主要成果:

微RNA提供了一个强大的机制,用于微调工程细胞中的基因表达.
成功整合miRNAs可以改善对细胞反应的控制和治疗疗效.
这些例子展示了在先进的细胞疗法中使用miRNA的可行性和好处.

结论:

微RNAs代表了一个有价值的,但尚未充分利用的组件,用于增强工程细胞疗法.
未来的细胞工程工作应该越来越多地考虑miRNAs的战略使用,以实现精确的治疗控制.
利用miRNA介导的基因调节可以推动下一代基于细胞的药物开发的创新.

关键词:

细胞疗法是一种细胞疗法.没有编码的RNA.合成生物学合成生物学一个T细胞细胞.miR-17∼92 的使用量.这是一个微型RNA.

更多相关视频

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

相关概念视频

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

Experimental RNAi

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...

siRNA - Small Interfering RNAs

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...